ACTO Unveils CxZone: An Innovative AI-Powered Roleplay Solution for Pharma Experts

Introducing CxZone: A Transformative Solution for Pharma Field Professionals



In the rapidly evolving pharmaceutical industry, the ability to engage healthcare professionals (HCPs) effectively is paramount. Recognizing the need for a more dynamic training tool, ACTO has introduced CxZone, a revolutionary AI-simulated roleplay solution. Designed specifically for pharmaceutical sales representatives and medical science liaisons (MSLs), CxZone integrates seamlessly with Veeva PromoMats and MedComms, creating a robust environment for learning and skill enhancement.

What is CxZone?


CxZone stands out as the first and only AI-driven roleplay solution tailored exclusively for pharma professionals. Its primary goal is to enrich customer experience by enabling field teams to refine their clinical conversations. Through a combination of gamification, real-time feedback, and a continuously updated content library, CxZone offers a highly interactive training experience.

Key Features and Benefits


One of the most compelling aspects of CxZone is its ability to offer judgment-free, on-demand practice sessions. Reps can engage in realistic scenarios that mirror actual HCP interactions. The roleplay tool focuses on critical areas such as clinical fluency and product messaging, ensuring that representatives can converse confidently and competently about their products. The content within CxZone is synchronized with Veeva's promotional materials, ensuring that users always practice with the most current and approved resources available.

Customized Learning Experience

The training model utilizes ACTO’s proprietary Empathetic AI engine, which allows users to create practice avatars that reflect the characteristics of their target HCPs. This customization extends to therapeutic areas, emotional tones, and even the complexity of clinical questions posed during practice sessions. As reps engage with these simulations, they receive instant feedback aligned with their company's selling strategies and coaching models.

Enhanced Personalization with 'My HCP'

In addition to its foundational capabilities, ACTO is set to launch My HCP, which will elevate the personalization of the simulations. By integrating data from Veeva Vault CRM, such as prescribing habits and patient volumes, My HCP will allow reps to interact with realistic digital twins of their actual clients. This deeper insight will help sales professionals anticipate and navigate HCP concerns and interests more effectively.

Why CxZone Matters


According to Parth Khanna, ACTO's CEO, the success of new therapies is heavily reliant on the ability of field teams to engage with HCPs in meaningful ways. CxZone is designed to tackle industry challenges, including limited access to HCPs and inconsistent coaching methods. By providing a gamified, AI-enhanced environment for practice, CxZone fosters an atmosphere of continuous improvement, allowing representatives to sharpen their skills significantly.

Customer Feedback and Impact


Early reactions from industry leaders, like Sheryl Bisson, Senior Manager of Training Development at Johnson & Johnson Vision, highlight that CxZone is set to enhance representatives' confidence and abilities in clinical discussions. With its innovative approach to learning, CxZone not only helps reinforce product knowledge but also supports the development of authentic and effective communication strategies that resonate with healthcare providers.

Conclusion


As ACTO continues to lead the charge in AI-first commercial learning solutions, CxZone represents a groundbreaking step in the evolution of pharma training. By integrating cutting-edge technology with real-world insights, this roleplay platform is poised to redefine the customer experience in the life sciences sector.

For more information on CxZone or to request a demo, visit ACTO's website or connect with ACTO on LinkedIn to stay updated on their latest advancements and offerings.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.